Citations (27)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (27)
Valentina Echeverria, Cristhian Mendoza & Alex Iarkov. (2023) Nicotinic acetylcholine receptors and learning and memory deficits in Neuroinflammatory diseases. Frontiers in Neuroscience 17.
Crossref
Crossref
Daniela Braida, Luisa Ponzoni, Milena Moretti, Paola Viani, Marco Pallavicini, Cristiano Bolchi, Rebecca Appiani, Francesco Bavo, Cecilia Gotti & Mariaelvina Sala. (2020) Behavioural and pharmacological profiles of zebrafish administrated pyrrolidinyl benzodioxanes and prolinol aryl ethers with high affinity for heteromeric nicotinic acetylcholine receptors. Psychopharmacology 237:8, pages 2317-2326.
Crossref
Crossref
Hugo Geerts & James E. Barrett. (2019) Neuronal Circuit-Based Computer Modeling as a Phenotypic Strategy for CNS R&D. Frontiers in Neuroscience 13.
Crossref
Crossref
Hugo Geerts, Athan Spiros & Patrick Roberts. (2018) Impact of amyloid-beta changes on cognitive outcomes in Alzheimer’s disease: analysis of clinical trials using a quantitative systems pharmacology model. Alzheimer's Research & Therapy 10:1.
Crossref
Crossref
Alan S. Lewis, Gerrit Ian van Schalkwyk, Mayra Ortiz Lopez, Fred R. Volkmar, Marina R. Picciotto & Denis G. Sukhodolsky. (2018) An Exploratory Trial of Transdermal Nicotine for Aggression and Irritability in Adults with Autism Spectrum Disorder. Journal of Autism and Developmental Disorders 48:8, pages 2748-2757.
Crossref
Crossref
Dean F Wong, Hiroto Kuwabara, Andrew G Horti, Joshua M Roberts, Ayon Nandi, Nicola Cascella, James Brasic, Elise M Weerts, Kelly Kitzmiller, Jenny A Phan, Lorena Gapasin, Akira Sawa, Heather Valentine, Gary Wand, Chakradhar Mishra, Noble George, Michael McDonald, Wojtek Lesniak, Daniel P Holt, Babak B Azad, Robert F Dannals, William Kem, Robert Freedman & Albert Gjedde. (2018) Brain PET Imaging of α7-nAChR with [18F]ASEM: Reproducibility, Occupancy, Receptor Density, and Changes in Schizophrenia. International Journal of Neuropsychopharmacology 21:7, pages 656-667.
Crossref
Crossref
Irina Shelukhina, Ekaterina Spirova, Denis Kudryavtsev, Lucy Ojomoko, Markus Werner, Christoph Methfessel, Michael Hollmann & Victor Tsetlin. (2017) Calcium imaging with genetically encoded sensor Case12: Facile analysis of α7/α9 nAChR mutants. PLOS ONE 12:8, pages e0181936.
Crossref
Crossref
Tangui Maurice & Nino Goguadze. 2017. Sigma Receptors: Their Role in Disease and as Therapeutic Targets. Sigma Receptors: Their Role in Disease and as Therapeutic Targets
213
233
.
Hans O. Kalkman & Dominik Feuerbach. (2016) Modulatory effects of α7 nAChRs on the immune system and its relevance for CNS disorders. Cellular and Molecular Life Sciences 73:13, pages 2511-2530.
Crossref
Crossref
Verner Knott, Danielle Impey, Joelle Choueiry, Dylan Smith, Sara de la Salle, Salman Saghir, Meaghan Smith, Elise Beaudry, Vadim Ilivitsky & Alain Labelle. (2015) An acute dose, randomized trial of the effects of CDP-Choline on Mismatch Negativity (MMN) in healthy volunteers stratified by deviance detection level. Neuropsychiatric Electrophysiology 1:1.
Crossref
Crossref
Xiomara A. Perez. (2015) Preclinical Evidence for a Role of the Nicotinic Cholinergic System in Parkinson?s Disease. Neuropsychology Review 25:4, pages 371-383.
Crossref
Crossref
Mark J. Millan, Guy M. Goodwin, Andreas Meyer-Lindenberg & Sven Ove Ögren. (2015) Learning from the past and looking to the future: Emerging perspectives for improving the treatment of psychiatric disorders. European Neuropsychopharmacology 25:5, pages 599-656.
Crossref
Crossref
Hugo Geerts, Patrick Roberts, Athan Spiros & Steven Potkin. (2015) Understanding responder neurobiology in schizophrenia using a quantitative systems pharmacology model: Application to iloperidone. Journal of Psychopharmacology 29:4, pages 372-382.
Crossref
Crossref
Verner Knott, Sara de la Salle, Joelle Choueiry, Danielle Impey, Dylan Smith, Meaghan Smith, Elise Beaudry, Salman Saghir, Vadim Ilivitsky & Alain Labelle. (2015) Neurocognitive effects of acute choline supplementation in low, medium and high performer healthy volunteers. Pharmacology Biochemistry and Behavior 131, pages 119-129.
Crossref
Crossref
Roy Yaari & Ann Hake. (2015) Alzheimer's disease clinical trials: past failures and future opportunities. Clinical Investigation 5:3, pages 297-309.
Crossref
Crossref
Maryka Quik, Tanuja Bordia, Danhui Zhang & Xiomara A. Perez. 2015. Nicotine Use in Mental Illness and Neurological Disorders. Nicotine Use in Mental Illness and Neurological Disorders
247
271
.
Caroline Ménard, Pierrette Gaudreau & Rémi Quirion. 2015. Cognitive Enhancement. Cognitive Enhancement
59
98
.
Verner Knott, Dylan Smith, Sara de la Salle, Danielle Impey, Joelle Choueiry, Elise Beaudry, Meaghan Smith, Salman Saghir, Vadim Ilivitsky & Alain Labelle. (2014) CDP-choline: Effects of the procholine supplement on sensory gating and executive function in healthy volunteers stratified for low, medium and high P50 suppression. Journal of Psychopharmacology 28:12, pages 1095-1108.
Crossref
Crossref
Reinoud Maex, Vladimir P. Grinevich, Valentina Grinevich, Evgeny Budygin, Merouane Bencherif & Boris Gutkin. (2014) Understanding the Role α7 Nicotinic Receptors Play in Dopamine Efflux in Nucleus Accumbens. ACS Chemical Neuroscience 5:10, pages 1032-1040.
Crossref
Crossref
Danhui Zhang, Matthew McGregor, Michael W. Decker & Maryka Quik. (2014)
The
α
7 Nicotinic Receptor Agonist ABT-107 Decreases l-Dopa–Induced Dyskinesias in Parkinsonian Monkeys
. Journal of Pharmacology and Experimental Therapeutics 351:1, pages 25-32.
Crossref
Crossref
Daniel Umbricht, Richard SE Keefe, Stephen Murray, David A Lowe, Richard Porter, George Garibaldi & Luca Santarelli. (2014) A Randomized, Placebo-Controlled Study Investigating the Nicotinic α7 Agonist, RG3487, for Cognitive Deficits in Schizophrenia. Neuropsychopharmacology 39:7, pages 1568-1577.
Crossref
Crossref
Robert L. Gannon, David A. Garcia & Mark J. Millan. (2014) Effects of systemically applied nAChR?7 agonists and antagonists on light-induced phase shifts of hamster circadian activity rhythms. European Neuropsychopharmacology 24:6, pages 964-973.
Crossref
Crossref
Jared W. Young & Mark A. Geyer. (2013) Evaluating the role of the alpha-7 nicotinic acetylcholine receptor in the pathophysiology and treatment of schizophrenia. Biochemical Pharmacology 86:8, pages 1122-1132.
Crossref
Crossref
Katja S. Kroker, Jens Moreth, Lothar Kussmaul, Georg Rast & Holger Rosenbrock. (2013) Restoring long-term potentiation impaired by amyloid-beta oligomers: Comparison of an acetylcholinesterase inhibitior and selective neuronal nicotinic receptor agonists. Brain Research Bulletin 96, pages 28-38.
Crossref
Crossref
Bal?zs Lendvai, Ferenc Kassai, ?gota Sz?jli & Zsolt N?methy. (2013) ?7 Nicotinic acetylcholine receptors and their role in cognition. Brain Research Bulletin 93, pages 86-96.
Crossref
Crossref
Trevor W. Stone, Nicholas Stoy & L. Gail Darlington. (2013) An expanding range of targets for kynurenine metabolites of tryptophan. Trends in Pharmacological Sciences 34:2, pages 136-143.
Crossref
Crossref
Deepak Cyril D'Souza, Kyungheup Ahn, Savita Bhakta, Jacqueline Elander, Nagendra Singh, Haleh Nadim, Peter Jatlow, Raymond F. Suckow, Brian Pittman & Mohini Ranganathan. (2012) Nicotine Fails to Attenuate Ketamine-Induced Cognitive Deficits and Negative and Positive Symptoms in Humans: Implications for Schizophrenia. Biological Psychiatry 72:9, pages 785-794.
Crossref
Crossref